Published in Immunity on May 03, 2012
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 4.75
Immunology of psoriasis. Annu Rev Immunol (2014) 2.06
Regulatory T cells in nonlymphoid tissues. Nat Immunol (2013) 1.69
The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med (2015) 1.69
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood (2013) 1.54
Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS One (2015) 1.46
The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol (2013) 1.36
Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest (2013) 1.33
Functions of the skin microbiota in health and disease. Semin Immunol (2013) 1.22
Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol (2013) 1.13
Antigen presentation by Langerhans cells. Curr Opin Immunol (2012) 1.08
Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog (2014) 1.01
Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. J Immunol (2014) 1.00
Vascularized composite allograft tolerance across MHC barriers in a large animal model. Am J Transplant (2014) 0.98
Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans. J Immunol (2013) 0.97
Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Adv Immunol (2013) 0.95
Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology (2014) 0.95
Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species? Front Immunol (2015) 0.95
Human dendritic cell subsets in vaccination. Curr Opin Immunol (2013) 0.93
A three-dimensional atlas of human dermal leukocytes, lymphatics, and blood vessels. J Invest Dermatol (2013) 0.93
Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med (2015) 0.92
Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. J Exp Med (2015) 0.92
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes. PLoS One (2013) 0.89
Tissue-resident T cells: dynamic players in skin immunity. Front Immunol (2014) 0.89
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation. PLoS One (2013) 0.87
Interactions between host factors and the skin microbiome. Cell Mol Life Sci (2014) 0.87
Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus. J Invest Dermatol (2013) 0.86
The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging. J Invest Dermatol (2015) 0.85
Tracking and quantification of dendritic cell migration and antigen trafficking between the skin and lymph nodes. Sci Rep (2014) 0.85
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol (2014) 0.84
Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features. Front Immunol (2013) 0.84
Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation. J Invest Dermatol (2013) 0.84
IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals. Cytokine (2013) 0.83
Dendritic cells in the periphery control antigen-specific natural and induced regulatory T cells. Front Immunol (2013) 0.83
The known unknowns of the human dendritic cell network. Front Immunol (2015) 0.82
Natural compounds and aging: between autophagy and inflammasome. Biomed Res Int (2014) 0.82
ABCB5 Identifies Immunoregulatory Dermal Cells. Cell Rep (2015) 0.82
Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis. PLoS One (2015) 0.80
Dendritic cells and vaccine design for sexually-transmitted diseases. Microb Pathog (2012) 0.80
The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol (2016) 0.79
Tailored immunity by skin antigen-presenting cells. Hum Vaccin Immunother (2014) 0.79
The pathophysiological role of dendritic cell subsets in psoriasis. BMB Rep (2014) 0.78
The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin. Ann N Y Acad Sci (2015) 0.78
Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells. PLoS One (2015) 0.78
Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. Prog Lipid Res (2016) 0.78
TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis. Oncotarget (2016) 0.77
Dendritic cells from oral cavity induce Foxp3(+) regulatory T cells upon antigen stimulation. PLoS One (2012) 0.77
Autoinflammatory Skin Disorders: The Inflammasomme in Focus. Trends Mol Med (2016) 0.77
Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major. J Res Med Sci (2014) 0.77
Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1(+) DCs in mouse and human and distinguishes them from Langerhans cells. J Immunol Methods (2016) 0.77
Emerging Skin T-Cell Functions in Response to Environmental Insults. J Invest Dermatol (2016) 0.76
Immunology and skin in health and disease. Cold Spring Harb Perspect Med (2014) 0.76
Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells. Cell Mol Immunol (2015) 0.76
Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis. J Invest Dermatol (2015) 0.76
Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments. Genome Med (2014) 0.76
Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination. Oncoimmunology (2013) 0.76
Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol (2016) 0.75
Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice. Sci Rep (2016) 0.75
Dendritic cell analysis in primary immunodeficiency. Curr Opin Allergy Clin Immunol (2016) 0.75
Solid-in-oil nanodispersions for transdermal drug delivery systems. Biotechnol J (2016) 0.75
Triggering through NOD-2 Differentiates Bone Marrow Precursors to Dendritic Cells with Potent Bactericidal activity. Sci Rep (2016) 0.75
Langerhans cell precursors acquire RANK/CD265 in prenatal human skin. Acta Histochem (2015) 0.75
In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells. J Invest Dermatol (2015) 0.75
Skin sensitization induced Langerhans' cell mobilization: variable requirements for tumour necrosis factor-α. Immunology (2015) 0.75
Novel concept of iSALT (inducible skin-associated lymphoid tissue) in the elicitation of allergic contact dermatitis. Proc Jpn Acad Ser B Phys Biol Sci (2016) 0.75
Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance. Hum Vaccin Immunother (2016) 0.75
Pre-existing central nervous system lesions negate cytokine requirements for regional experimental autoimmune encephalomyelitis development. Immunology (2013) 0.75
UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin. J Invest Dermatol (2015) 0.75
Self-Assembly DNA Polyplex Vaccine inside Dissolving Microneedles for High-Potency Intradermal Vaccination. Theranostics (2017) 0.75
A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. JCI Insight (2017) 0.75
Regulatory T cells in Skin. Immunology (2017) 0.75
Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol (2016) 0.75
Ontogeny and function of murine epidermal Langerhans cells. Nat Immunol (2017) 0.75
RelB(+) Steady-State Migratory Dendritic Cells Control the Peripheral Pool of the Natural Foxp3(+) Regulatory T Cells. Front Immunol (2017) 0.75
Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol (2017) 0.75
The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol (2007) 12.72
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity (2009) 9.01
FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol (2010) 8.73
Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 6.62
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol (2006) 6.22
The vast majority of CLA+ T cells are resident in normal skin. J Immunol (2006) 5.43
Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 4.64
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol (2007) 4.29
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol (2008) 4.17
Identification of a novel population of Langerin+ dendritic cells. J Exp Med (2007) 4.13
A prescription for human immunology. Immunity (2008) 4.09
Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 4.06
Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science (2008) 3.97
Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 3.94
Response to self antigen imprints regulatory memory in tissues. Nature (2011) 2.96
Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol (2009) 2.76
Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med (2010) 2.61
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest (2007) 2.46
Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol (2009) 2.31
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med (2012) 2.22
External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med (2009) 1.95
A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol (2006) 1.86
Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med (2008) 1.85
Resident and "inflammatory" dendritic cells in human skin. J Invest Dermatol (2008) 1.72
In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol (2010) 1.71
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med (2008) 1.67
IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood (2006) 1.64
Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol (2009) 1.60
Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol (2009) 1.54
Acute ablation of Langerhans cells enhances skin immune responses. J Immunol (2010) 1.47
The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest (2008) 1.46
Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol (2000) 1.45
Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A (2009) 1.44
gammadelta T cells: firefighters or fire boosters in the front lines of inflammatory responses. Immunol Rev (2007) 1.31
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood (2004) 1.29
Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol (2009) 1.16
Harnessing human dendritic cell subsets to design novel vaccines. Ann N Y Acad Sci (2009) 1.12
Immunology taught by humans. Sci Transl Med (2012) 1.08
Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells. J Invest Dermatol (2010) 0.98
Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells. J Immunol (2010) 0.95
Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity. J Immunol Methods (2009) 0.95
Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha. J Invest Dermatol (2001) 0.95
Potential of tolerogenic dendritic cells for transplantation. Semin Immunol (2001) 0.93
The purification and functional analysis of human CD4+CD25high regulatory T cells. Curr Protoc Immunol (2006) 0.93
Revisiting the tolerogenicity of epidermal Langerhans cells. Immunol Cell Biol (2010) 0.88
A novel Candida albicans skin test antigen: efficacy and safety in man. J Biol Stand (1988) 0.88
The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system? Immunol Cell Biol (2010) 0.86
Superantigen-like effects of a Candida albicans polypeptide. J Infect Dis (2008) 0.83
Candida albicans induces selective expansion of human T lymphocytes expressing the T-cell receptor variable region V beta 5.1. J Dermatol Sci (1996) 0.78
Identification of cells initiating human melanomas. Nature (2008) 8.28
The vast majority of CLA+ T cells are resident in normal skin. J Immunol (2006) 5.43
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 4.64
Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med (2010) 2.61
Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS One (2011) 2.22
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med (2012) 2.22
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med (2011) 2.14
CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. Nat Immunol (2010) 2.13
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med (2012) 2.11
The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol (2006) 2.06
Dynamic programming of CD8+ T cell trafficking after live viral immunization. Immunity (2006) 1.98
A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol (2006) 1.86
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood (2010) 1.85
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med (2008) 1.67
IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood (2006) 1.64
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res (2011) 1.62
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest (2012) 1.61
Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood (2007) 1.59
IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J Immunol (2003) 1.56
Human regulatory T cells and autoimmunity. Eur J Immunol (2008) 1.54
Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J Clin Invest (2003) 1.43
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium. J Immunol (2010) 1.42
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood (2003) 1.36
Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Clin Cancer Res (2010) 1.31
CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. J Invest Dermatol (2012) 1.23
CD43 is a ligand for E-selectin on CLA+ human T cells. Blood (2005) 1.17
Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots. J Immunol (2002) 1.15
Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol (2002) 1.15
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res (2013) 1.15
Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med (2014) 1.15
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol (2009) 1.13
T-cell distribution and adhesion receptor expression in metastatic melanoma. Clin Cancer Res (2007) 1.12
Human skin cells support thymus-independent T cell development. J Clin Invest (2005) 1.11
Embryonic trafficking of gammadelta T cells to skin is dependent on E/P selectin ligands and CCR4. Proc Natl Acad Sci U S A (2010) 1.08
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol (2013) 1.06
Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol (2005) 1.06
Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation. J Immunol (2010) 1.04
IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis. J Immunol (2003) 1.04
Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells. Proc Natl Acad Sci U S A (2013) 1.03
Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Clin Cancer Res (2006) 1.02
Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma. Clin Cancer Res (2005) 1.01
Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood (2002) 0.98
CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes. J Immunol (2013) 0.97
Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol (2004) 0.97
First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res (2010) 0.96
Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood (2005) 0.96
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood (2012) 0.95
Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus. J Invest Dermatol (2008) 0.95
Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest (2006) 0.94
Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol (2007) 0.93
Interleukin-16 as a marker of Sézary syndrome onset and stage. J Clin Immunol (2010) 0.93
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biol Blood Marrow Transplant (2004) 0.92
Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J Invest Dermatol (2012) 0.92
The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression. Exp Dermatol (2012) 0.90
Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma. Leuk Lymphoma (2012) 0.90
High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Blood (2010) 0.90
Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol (2005) 0.89
Imiquimod: a topically applied link between innate and acquired immunity. Arch Dermatol (2003) 0.88
Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Arch Dermatol (2003) 0.88
Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice. J Immunol (2009) 0.88
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell (2016) 0.87
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle (2014) 0.86
Counter-regulation of interleukin-1alpha (IL-1alpha) and IL-1 receptor antagonist in murine keratinocytes. J Invest Dermatol (2005) 0.85
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells. Mol Cancer Ther (2012) 0.85
Identification of autoantigens in psoriatic plaques using expression cloning. J Invest Dermatol (2004) 0.84
Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma. Arch Dermatol Res (2010) 0.83
Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol (2012) 0.82
Mapping susceptibility genes for the induction of pulmonary fibrosis in mice. Chest (2002) 0.81
Mycosis fungoides presenting at the site of a transdermal estradiol patch. J Am Acad Dermatol (2012) 0.81
Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma. PLoS One (2012) 0.80
Basic fibroblast growth factor treatment for skin ulcerations in scleroderma. Cutis (2005) 0.78
Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res (2005) 0.78
Retracted Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma. J Clin Invest (2011) 0.77
CXCR4 pathway associated with family history of melanoma. Cancer Causes Control (2013) 0.76
Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection. J Invest Dermatol (2012) 0.76
Complete remission in a patient with angiosarcoma by the combination of OK-432, rhIL-2, and radiotherapy. Eur J Dermatol (2005) 0.75
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol (2013) 0.75
Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology. Clin Dermatol (2008) 0.75